{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Péricytes : Questions médicales les plus fréquentes",
"headline": "Péricytes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Péricytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2025-03-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Péricytes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mésoderme",
"url": "https://questionsmedicales.fr/mesh/D008648",
"about": {
"@type": "MedicalCondition",
"name": "Mésoderme",
"code": {
"@type": "MedicalCode",
"code": "D008648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Péricytes",
"alternateName": "Pericytes",
"code": {
"@type": "MedicalCode",
"code": "D020286",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alexander Birbrair",
"url": "https://questionsmedicales.fr/author/Alexander%20Birbrair",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Patologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil. birbrair@icb.ufmg.br."
}
},
{
"@type": "Person",
"name": "John C Chappell",
"url": "https://questionsmedicales.fr/author/John%20C%20Chappell",
"affiliation": {
"@type": "Organization",
"name": "Center for Heart and Reparative Medicine Research, Fralin Biomedical Research Institute at Virginia Tech-Carilion, Roanoke, VA 24016, USA."
}
},
{
"@type": "Person",
"name": "Nusrat S Khan",
"url": "https://questionsmedicales.fr/author/Nusrat%20S%20Khan",
"affiliation": {
"@type": "Organization",
"name": "BHF Centre for Cardiovascular Science, Queen's Medical Research Center, University of Edinburgh, Edinburgh, UK."
}
},
{
"@type": "Person",
"name": "Chi F Hung",
"url": "https://questionsmedicales.fr/author/Chi%20F%20Hung",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA."
}
},
{
"@type": "Person",
"name": "Carole L Wilson",
"url": "https://questionsmedicales.fr/author/Carole%20L%20Wilson",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37373091",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24129945"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating Causal Associations of Diet-Derived Circulating Antioxidants with the Risk of Digestive System Cancers: A Mendelian Randomization Study.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35956413",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14153237"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Relationship Between Plant-Based Diet and Risk of Digestive System Cancers: A Meta-Analysis Based on 3,059,009 Subjects.",
"datePublished": "2022-06-03",
"url": "https://questionsmedicales.fr/article/35719615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.892153"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adverse events of immune checkpoint inhibitors for patients with digestive system cancers: A systematic review and meta-analysis.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36341450",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1013186"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plant-based dietary patterns and the risk of digestive system cancers in 3 large prospective cohort studies.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37101016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10654-023-01007-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures de l'embryon",
"item": "https://questionsmedicales.fr/mesh/D004628"
},
{
"@type": "ListItem",
"position": 3,
"name": "Feuillets embryonnaires",
"item": "https://questionsmedicales.fr/mesh/D005855"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mésoderme",
"item": "https://questionsmedicales.fr/mesh/D008648"
},
{
"@type": "ListItem",
"position": 5,
"name": "Péricytes",
"item": "https://questionsmedicales.fr/mesh/D020286"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Péricytes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Péricytes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Péricytes",
"description": "Comment diagnostiquer une dysfonction des péricytes ?\nQuels tests sont utilisés pour évaluer les péricytes ?\nLes péricytes peuvent-ils être visualisés par IRM ?\nY a-t-il des marqueurs spécifiques pour les péricytes ?\nLes tests génétiques sont-ils utiles pour les péricytes ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Péricytes",
"description": "Quels symptômes indiquent une dysfonction des péricytes ?\nLes péricytes affectent-ils la vision ?\nPeut-on observer des symptômes neurologiques liés aux péricytes ?\nLes péricytes sont-ils liés à des douleurs chroniques ?\nLes péricytes peuvent-ils causer des troubles cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Péricytes",
"description": "Comment prévenir les dysfonctionnements des péricytes ?\nLe contrôle de la pression artérielle aide-t-il les péricytes ?\nLes habitudes alimentaires influencent-elles les péricytes ?\nL'exercice physique est-il bénéfique pour les péricytes ?\nLe tabagisme affecte-t-il les péricytes ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Péricytes",
"description": "Quels traitements existent pour les dysfonctionnements des péricytes ?\nLes thérapies géniques peuvent-elles aider les péricytes ?\nLes médicaments vasodilatateurs sont-ils efficaces ?\nY a-t-il des traitements naturels pour les péricytes ?\nLa rééducation peut-elle aider les patients avec des problèmes de péricytes ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Péricytes",
"description": "Quelles complications peuvent survenir avec des péricytes dysfonctionnels ?\nLes péricytes sont-ils liés à des maladies neurodégénératives ?\nLes complications cardiaques sont-elles possibles ?\nLes péricytes affectent-ils la cicatrisation des plaies ?\nLes complications rénales sont-elles possibles avec des péricytes altérés ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Péricytes",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des péricytes ?\nL'âge est-il un facteur de risque pour les péricytes ?\nLe stress influence-t-il les péricytes ?\nLes maladies métaboliques augmentent-elles les risques ?\nL'obésité est-elle un facteur de risque pour les péricytes ?",
"url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Digestive+System+Neoplasms&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des péricytes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des biopsies tissulaires et des techniques d'imagerie avancées."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les péricytes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests histologiques et des analyses immunohistochimiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les péricytes peuvent-ils être visualisés par IRM ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut aider à visualiser les changements vasculaires associés aux péricytes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour les péricytes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme NG2 et PDGFR-β sont utilisés pour identifier les péricytes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les péricytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent aider à identifier des mutations affectant les péricytes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction des péricytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'œdème, la douleur et des troubles circulatoires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les péricytes affectent-ils la vision ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction peut entraîner des problèmes de circulation dans la rétine."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques liés aux péricytes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles vasculaires cérébraux peuvent causer des symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les péricytes sont-ils liés à des douleurs chroniques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dysfonction des péricytes peut contribuer à des douleurs chroniques par une mauvaise circulation."
}
},
{
"@type": "Question",
"name": "Les péricytes peuvent-ils causer des troubles cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies des péricytes peuvent affecter la circulation et contribuer à des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des péricytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, avec une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le contrôle de la pression artérielle aide-t-il les péricytes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle de la pression artérielle préserve la santé des péricytes."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les péricytes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et en oméga-3 peut soutenir la santé des péricytes."
}
},
{
"@type": "Question",
"name": "L'exercice physique est-il bénéfique pour les péricytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la fonction des péricytes."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les péricytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme nuit à la santé vasculaire et peut altérer la fonction des péricytes."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les dysfonctionnements des péricytes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies médicamenteuses et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles aider les péricytes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour corriger les anomalies des péricytes."
}
},
{
"@type": "Question",
"name": "Les médicaments vasodilatateurs sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vasodilatateurs peuvent améliorer la circulation en agissant sur les péricytes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les péricytes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches naturelles, comme les antioxydants, peuvent soutenir la santé vasculaire."
}
},
{
"@type": "Question",
"name": "La rééducation peut-elle aider les patients avec des problèmes de péricytes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation peut améliorer la circulation et la fonction vasculaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des péricytes dysfonctionnels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles circulatoires, des œdèmes et des maladies vasculaires."
}
},
{
"@type": "Question",
"name": "Les péricytes sont-ils liés à des maladies neurodégénératives ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction des péricytes peut contribuer à des maladies comme Alzheimer."
}
},
{
"@type": "Question",
"name": "Les complications cardiaques sont-elles possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de péricytes peuvent entraîner des maladies cardiaques ischémiques."
}
},
{
"@type": "Question",
"name": "Les péricytes affectent-ils la cicatrisation des plaies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dysfonction des péricytes peut retarder la cicatrisation en affectant la vascularisation."
}
},
{
"@type": "Question",
"name": "Les complications rénales sont-elles possibles avec des péricytes altérés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des péricytes dysfonctionnels peuvent contribuer à des maladies rénales chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des péricytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les péricytes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des péricytes et la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les péricytes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut nuire à la santé vasculaire et affecter les péricytes."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète augmentent le risque de dysfonction des péricytes."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque pour les péricytes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à des troubles vasculaires et à une dysfonction des péricytes."
}
}
]
}
]
}
While gastrointestinal tumors remain a multifactorial and prevalent group of malignancies commonly treated surgically in combination with chemotherapy and radiotherapy, advancements regarding immunoth...
Molecular mechanisms and observational studies have found that diet-derived antioxidants are associated with digestive system cancers, whereas there is a lack of causal evidence from randomized clinic...
Diets containing red or processed meat are associated with a growing risk of digestive system cancers. Whether a plant-based diet is protective against cancer needs a high level of statistical evidenc...
We performed a meta-analysis of five English databases, including PubMed, Medline, Embase, Web of Science databases, and Scopus, on October 24, 2021 to identify published papers. Cohort studies or cas...
The same results were found in cohort (adjusted RR = 0.82, 95% CI: 0.78-0.86,...
Plant-based diets were protective against cancers of the digestive system, with no significant differences between different types of cancer....
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022322276, Identifier: CRD42022322276....
To study the incidence and distribution of adverse events in immune checkpoint inhibitors (ICI) for digestive system cancers and to provide a reference for the safe, rational, and effective use of imm...
We searched for articles published in English between January 1, 2010, and May 18, 2022. All clinical trials of ICI-based therapies for digestive system cancers were investigated, including only rando...
We searched 2048 records, of which 21 studies (7108 patients) were eligible for inclusion. The incidence of ICI trAEs of any grade was 82.7% (95% CI 73.9-90.0), and the incidence of grade 3 or higher ...
Our meta-analysis summarizes AEs associated with ICI in digestive system cancers. The incidence, characteristics, and distribution of AEs vary by cancer type, combination therapy modality, and differe...
Little is known about the relation between plant-based dietary patterns and digestive system cancers. This study investigated the prospective association between 3 pre-defined indices of plant-based d...
We aimed to determine the impact of fibroblast activation protein inhibitor (FAPI)-directed molecular imaging on staging and therapeutic management in patients affected with digestive system tumors wh...
Thirty-two patients with tumors of the digestive system were included: colon adenocarcinoma, 2/32 (6.3%); hepatocellular carcinoma (HCC), 6/32 (18.8%); pancreatic duct adenocarcinoma (PDAC), 6/32 (18....
Compared with GCI, 68 Ga-FAPI-04 PET/CT led to staging changes in 15/32 patients (46.9%). Among those, downstaging was recorded in 3/15 cases (20.0%) and upstaging in the remaining 12/15 patients (HCC...
In patients affected with digestive system tumors, 68 Ga-FAPI-04 PET/CT resulted in staging changes in more than 46% and therapeutic modifications in 25% of the cases, in particular in patients with H...
Panel gene sequencing is an established diagnostic tool for precision oncology of solid tumors, but its utility for the treatment of cancers of the digestive system in clinical routine is less well do...
We retrospectively identified patients with advanced or metastatic gastrointestinal, pancreaticobiliary or hepatic cancers who received panel gene sequencing at a tertiary university hospital from 201...
In total, 155 patients received panel gene sequencing using either the Oncomine Focus (62 cases), Comprehensive (91 cases) or Childhood Cancer Research Assay (2 cases). The mean age of patients was 61...
Actionable genetic alterations are frequently detected by panel gene sequencing in patients with advanced cancers of the digestive tract, providing clinical benefit in selected cases. However, for the...
Patients with digestive system cancers (DSCs) are at a high risk for hospitalizations; however, the risk factors for readmission remain unknown. Here, we established a retrospective cohort study to as...
A total of 142,753 and 74,566 patients at index hospitalization were ultimately selected from the Nationwide Readmissions Database (NRD) 2018 to establish the 30-day and 180-day readmission cohorts, r...
The MUNO phenotype had 1.147-fold (95% CI: 1.066, 1.235;...
Both obesity and metabolic abnormalities are associated with a high risk for the poor prognosis of DSC patients. The effect of metabolic categories on the short- or long-term readmission of liver or p...
There is scant evidence regarding the effects of exercise type and duration on quality of life (QoL) in digestive system cancer (DSC) survivors. We aim to investigate the optimal type and duration of ...
A systematic literature search of PubMed, Embase, and Web of Science was performed. Eligibility for study inclusion was limited to studies that were randomized controlled trials involving all kinds of...
The analysis included 32 eligible articles and a total of 2558 participants. Our primary outcome indicated that short-term aerobic exercise significantly enhanced general health (standardized mean dif...
This study suggests that short-term aerobic exercise, with or without resistance exercise programs, enhances QoL (especially for general health) as well as relieves cancer-related symptoms for DSC sur...
Digestive system cancers represent a significant global health challenge and are attributed to a combination of demographic and lifestyle changes. Lipidomics has emerged as a pivotal area in cancer re...
Using a two-sample Mendelian randomization (MR) approach, we elucidated the causal relationships between lipidomic profiles and the risk of five types of digestive system cancer: stomach, liver, esoph...
Significant causal relationships were identified between certain lipidomic traits and the risk of developing digestive system cancers. Elevated sphingomyelin (d40:1) levels were associated with a redu...
Our findings underscore the significant causal relationships between specific lipidomic traits and the risk of developing various digestive system cancers, highlighting the potential of lipid profiles...